United States Cardiac Drug Stent Market Report 2017

Name: United States Cardiac Drug Stent Market Report 2017
Brand: QYResearch
SKU: UE2404F80E8EN
Price: 3800 USD
Availability: InStock

October 2017 | 112 pages | ID: UE2404F80E8EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Cardiac Drug Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cardiac Drug Stent in these regions, from 2012 to 2022 (forecast).

United States Cardiac Drug Stent market competition by top manufacturers/players, with Cardiac Drug Stent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Boston Scientific(US)
Cordis(US)
Abbott(US)
Advantec Vascular(US)
Braun Melsengen AG(Germany)
Biosensors(US)
Biotronik(Germany)
Blue Medical(Netherlands)
DISA Vascular(South Africa)
Essen(Germany)
Medtronic Vascular(Ireland)
MicroPort Medical(China）

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Durable Polymer Drug-eluting Stents
Bioabsorbable Polymer Drug-eluting Stent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cardiac Drug Stent for each application, including

Coronary Heart Disease
Clinical
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Cardiac Drug Stent Market Report 2017

1 CARDIAC DRUG STENT OVERVIEW

1.1 Product Overview and Scope of Cardiac Drug Stent
1.2 Classification of Cardiac Drug Stent by Product Category
  1.2.1 United States Cardiac Drug Stent Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cardiac Drug Stent Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Durable Polymer Drug-eluting Stents
  1.2.4 Bioabsorbable Polymer Drug-eluting Stent
1.3 United States Cardiac Drug Stent Market by Application/End Users
  1.3.1 United States Cardiac Drug Stent Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Coronary Heart Disease
  1.3.3 Clinical
  1.3.4 Others
1.4 United States Cardiac Drug Stent Market by Region
  1.4.1 United States Cardiac Drug Stent Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cardiac Drug Stent Status and Prospect (2012-2022)
  1.4.3 Southwest Cardiac Drug Stent Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cardiac Drug Stent Status and Prospect (2012-2022)
  1.4.5 New England Cardiac Drug Stent Status and Prospect (2012-2022)
  1.4.6 The South Cardiac Drug Stent Status and Prospect (2012-2022)
  1.4.7 The Midwest Cardiac Drug Stent Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cardiac Drug Stent (2012-2022)
  1.5.1 United States Cardiac Drug Stent Sales and Growth Rate (2012-2022)
  1.5.2 United States Cardiac Drug Stent Revenue and Growth Rate (2012-2022)

2 UNITED STATES CARDIAC DRUG STENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cardiac Drug Stent Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cardiac Drug Stent Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cardiac Drug Stent Average Price by Players/Suppliers (2012-2017)
2.4 United States Cardiac Drug Stent Market Competitive Situation and Trends
  2.4.1 United States Cardiac Drug Stent Market Concentration Rate
  2.4.2 United States Cardiac Drug Stent Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cardiac Drug Stent Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CARDIAC DRUG STENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cardiac Drug Stent Sales and Market Share by Region (2012-2017)
3.2 United States Cardiac Drug Stent Revenue and Market Share by Region (2012-2017)
3.3 United States Cardiac Drug Stent Price by Region (2012-2017)

4 UNITED STATES CARDIAC DRUG STENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cardiac Drug Stent Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cardiac Drug Stent Revenue and Market Share by Type (2012-2017)
4.3 United States Cardiac Drug Stent Price by Type (2012-2017)
4.4 United States Cardiac Drug Stent Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CARDIAC DRUG STENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cardiac Drug Stent Sales and Market Share by Application (2012-2017)
5.2 United States Cardiac Drug Stent Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CARDIAC DRUG STENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boston Scientific(US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cardiac Drug Stent Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boston Scientific(US) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cordis(US)
  6.2.2 Cardiac Drug Stent Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cordis(US) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abbott(US)
  6.3.2 Cardiac Drug Stent Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abbott(US) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Advantec Vascular(US)
  6.4.2 Cardiac Drug Stent Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Advantec Vascular(US) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Braun Melsengen AG(Germany)
  6.5.2 Cardiac Drug Stent Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Braun Melsengen AG(Germany) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biosensors(US)
  6.6.2 Cardiac Drug Stent Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biosensors(US) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biotronik(Germany)
  6.7.2 Cardiac Drug Stent Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biotronik(Germany) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Blue Medical(Netherlands)
  6.8.2 Cardiac Drug Stent Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Blue Medical(Netherlands) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 DISA Vascular(South Africa)
  6.9.2 Cardiac Drug Stent Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 DISA Vascular(South Africa) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Essen(Germany)
  6.10.2 Cardiac Drug Stent Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Essen(Germany) Cardiac Drug Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Medtronic Vascular(Ireland)
6.12 MicroPort Medical(China）

7 CARDIAC DRUG STENT MANUFACTURING COST ANALYSIS

7.1 Cardiac Drug Stent Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cardiac Drug Stent

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cardiac Drug Stent Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cardiac Drug Stent Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CARDIAC DRUG STENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cardiac Drug Stent Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cardiac Drug Stent Sales Volume Forecast by Type (2017-2022)
11.3 United States Cardiac Drug Stent Sales Volume Forecast by Application (2017-2022)
11.4 United States Cardiac Drug Stent Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Cardiac Drug Stent
Figure United States Cardiac Drug Stent Market Size (K Units) by Type (2012-2022)
Figure United States Cardiac Drug Stent Sales Volume Market Share by Type (Product Category) in 2016
Figure Durable Polymer Drug-eluting Stents Product Picture
Figure Bioabsorbable Polymer Drug-eluting Stent Product Picture
Figure United States Cardiac Drug Stent Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cardiac Drug Stent by Application in 2016
Figure Coronary Heart Disease Examples
Table Key Downstream Customer in Coronary Heart Disease
Figure Clinical Examples
Table Key Downstream Customer in Clinical
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Cardiac Drug Stent Market Size (Million USD) by Region (2012-2022)
Figure The West Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Drug Stent Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cardiac Drug Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Drug Stent Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cardiac Drug Stent Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cardiac Drug Stent Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Drug Stent Sales Share by Players/Suppliers
Figure 2017 United States Cardiac Drug Stent Sales Share by Players/Suppliers
Figure United States Cardiac Drug Stent Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cardiac Drug Stent Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cardiac Drug Stent Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Drug Stent Revenue Share by Players/Suppliers
Figure 2017 United States Cardiac Drug Stent Revenue Share by Players/Suppliers
Table United States Market Cardiac Drug Stent Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cardiac Drug Stent Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cardiac Drug Stent Market Share of Top 3 Players/Suppliers
Figure United States Cardiac Drug Stent Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cardiac Drug Stent Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cardiac Drug Stent Product Category
Table United States Cardiac Drug Stent Sales (K Units) by Region (2012-2017)
Table United States Cardiac Drug Stent Sales Share by Region (2012-2017)
Figure United States Cardiac Drug Stent Sales Share by Region (2012-2017)
Figure United States Cardiac Drug Stent Sales Market Share by Region in 2016
Table United States Cardiac Drug Stent Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cardiac Drug Stent Revenue Share by Region (2012-2017)
Figure United States Cardiac Drug Stent Revenue Market Share by Region (2012-2017)
Figure United States Cardiac Drug Stent Revenue Market Share by Region in 2016
Table United States Cardiac Drug Stent Price (USD/Unit) by Region (2012-2017)
Table United States Cardiac Drug Stent Sales (K Units) by Type (2012-2017)
Table United States Cardiac Drug Stent Sales Share by Type (2012-2017)
Figure United States Cardiac Drug Stent Sales Share by Type (2012-2017)
Figure United States Cardiac Drug Stent Sales Market Share by Type in 2016
Table United States Cardiac Drug Stent Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cardiac Drug Stent Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cardiac Drug Stent by Type (2012-2017)
Figure Revenue Market Share of Cardiac Drug Stent by Type in 2016
Table United States Cardiac Drug Stent Price (USD/Unit) by Types (2012-2017)
Figure United States Cardiac Drug Stent Sales Growth Rate by Type (2012-2017)
Table United States Cardiac Drug Stent Sales (K Units) by Application (2012-2017)
Table United States Cardiac Drug Stent Sales Market Share by Application (2012-2017)
Figure United States Cardiac Drug Stent Sales Market Share by Application (2012-2017)
Figure United States Cardiac Drug Stent Sales Market Share by Application in 2016
Table United States Cardiac Drug Stent Sales Growth Rate by Application (2012-2017)
Figure United States Cardiac Drug Stent Sales Growth Rate by Application (2012-2017)
Table Boston Scientific(US) Basic Information List
Table Boston Scientific(US) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific(US) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Boston Scientific(US) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Boston Scientific(US) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Cordis(US) Basic Information List
Table Cordis(US) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cordis(US) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Cordis(US) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Cordis(US) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Abbott(US) Basic Information List
Table Abbott(US) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott(US) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Abbott(US) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Abbott(US) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Advantec Vascular(US) Basic Information List
Table Advantec Vascular(US) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Advantec Vascular(US) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Advantec Vascular(US) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Advantec Vascular(US) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Braun Melsengen AG(Germany) Basic Information List
Table Braun Melsengen AG(Germany) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Braun Melsengen AG(Germany) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Braun Melsengen AG(Germany) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Braun Melsengen AG(Germany) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Biosensors(US) Basic Information List
Table Biosensors(US) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors(US) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Biosensors(US) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Biosensors(US) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Biotronik(Germany) Basic Information List
Table Biotronik(Germany) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotronik(Germany) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Biotronik(Germany) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Biotronik(Germany) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Blue Medical(Netherlands) Basic Information List
Table Blue Medical(Netherlands) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical(Netherlands) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Blue Medical(Netherlands) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Blue Medical(Netherlands) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table DISA Vascular(South Africa) Basic Information List
Table DISA Vascular(South Africa) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DISA Vascular(South Africa) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure DISA Vascular(South Africa) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure DISA Vascular(South Africa) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Essen(Germany) Basic Information List
Table Essen(Germany) Cardiac Drug Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Essen(Germany) Cardiac Drug Stent Sales Growth Rate (2012-2017)
Figure Essen(Germany) Cardiac Drug Stent Sales Market Share in United States (2012-2017)
Figure Essen(Germany) Cardiac Drug Stent Revenue Market Share in United States (2012-2017)
Table Medtronic Vascular(Ireland) Basic Information List
Table MicroPort Medical(China） Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiac Drug Stent
Figure Manufacturing Process Analysis of Cardiac Drug Stent
Figure Cardiac Drug Stent Industrial Chain Analysis
Table Raw Materials Sources of Cardiac Drug Stent Major Players/Suppliers in 2016
Table Major Buyers of Cardiac Drug Stent
Table Distributors/Traders List
Figure United States Cardiac Drug Stent Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Drug Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Drug Stent Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Type in 2022
Table United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Application in 2022
Table United States Cardiac Drug Stent Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cardiac Drug Stent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Drug Stent Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Cardiac Drug Stent Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports